Latest Health News Highlights: Mpox, Biotech IPOs, and Cancer Treatments

The latest health news covers a range of topics: India's confirmed mpox case from an older virus strain, MBX Biosciences' US IPO plans, AstraZeneca's trial results of a lung cancer drug, and Relay Therapeutics' promising breast cancer therapy. Other headlines include a lawsuit over Trojan condoms, improved safety protocols for Rezolute's low blood sugar treatment, EQT's acquisition of GeBBS Healthcare Solutions, Yale's fertility clinic settlement, Terns Pharmaceuticals' new weight-loss drug, and US legislative moves against Chinese biotech firms.

In a recent summary of health news, diverse developments in the sector were reported.

India announced that a recent mpox case was from an older strain, not the new one causing a global health emergency. MBX Biosciences plans to raise up to $482.5 million in its US IPO for peptide therapies targeting endocrine and metabolic disorders.

Meanwhile, AstraZeneca revealed that its lung cancer drug trial did not significantly improve overall survival rates. Relay Therapeutics reported that its breast cancer treatment shows promise, boosting its shares by 37%.

(With inputs from agencies.)